Post-approval studies (Phase 4)Study completedNCT01402089
What this trial is testing
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Who this might be right for
Non Small-cell Lung CancerRenal-cell CancerGastrointestinal Stroma Tumor
Markus Joerger 54